Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Te |
| Molecular Weight | 127.6 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Te]
InChI
InChIKey=VTLHPSMQDDEFRU-UHFFFAOYSA-N
InChI=1S/H2Te/h1H2
| Molecular Formula | Te |
| Molecular Weight | 127.6 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tellurium (Te) is widely used in industry. Tellurium (IV) compounds present antitumoral, immunomodulatory and neuroprotective effects due to their ability to inhibit cysteine proteases. Tellurium (IV) compounds exert anticonvulsant effects associated with the inhibition of caspases. Thus, organotellurium (IV) possesses a promising therapeutic potential as antiepileptogenic agents.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:45 GMT 2025
by
admin
on
Mon Mar 31 18:48:45 GMT 2025
|
| Record UNII |
NQA0O090ZJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1940
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
||
|
DSLD |
2062 (Number of products:26)
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10533
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | Merck Index | ||
|
Tellurium
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
6327182
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
NQA0O090ZJ
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
D013691
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
2532
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
13494-80-9
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
DTXSID9032119
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
30452
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
1311384
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | RxNorm | ||
|
C95192
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
NQA0O090ZJ
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
SUB182425
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
236-813-4
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY | |||
|
100000168891
Created by
admin on Mon Mar 31 18:48:45 GMT 2025 , Edited by admin on Mon Mar 31 18:48:45 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
